PaizaBio Introduces Aseptic Services for China Market
Contract manufacturer PiazaBio announces services for Western Pharma companies seeking to enter the China market.
PaizaBio, a contract manufacturer and marketing agent based in Albuquerque, NM, USA, has announced sterile injectable services for Western pharmaceutical companies seeking entry into China’s market.
PaizaBio reports in a company announcement that it has implemented processes and services to ensure quality, competitiveness, and transparency in China, including a training program for a qualified aseptic workforce; a digital and video production monitoring system; and lyophilization services.
The company’s manufacturing presence in China includes a 40,000-square-meter compound, encompassing a 25,000-square-meter production facility and 10,000-square-meter warehouse. Production equipment includes nine automated filling lines for vials, cartridges and syringes; 10 capping lines; a packaging facility with automated and manual options; four formulation tanks with a capacity of 3,000 liters; and laboratory facilities for testing, validation, analysis, and development. Additionally, the company offers clients expertise in Chinese regulatory compliance.
Soource: PaizaBio
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Prokaryotics Licenses Gram-Negative Antibiotic Potentiator from Northern Antibiotics
June 26th 2025Prokaryotics will gain worldwide rights to develop, manufacture, and commercialize NAB741, a non-bioactive polymyxin designed to increase permeability of the outer membrane of Gram-negative bacteria.
